Black Friday offer50% off your first month

Tesamorelin dosage: daily dosing, cycles & timing

Label doses & who sets yours

Two FDA-approved tesamorelin formulations carry two different daily doses. Here is what each label says, and how a Peppi clinician sets yours.

  • Black Friday: 50% Off Your First Month
  • 100% Money-Back Guarantee
  • Third-Party Lab Tested
  • Free 2-Day Shipping
Peppi pen

Tesamorelin is a lab‑made analog of growth hormone‑releasing factor, the brain signal that tells the pituitary to release growth hormone. The brand version, Egrifta, is FDA‑approved for one use: reducing excess abdominal fat in HIV‑infected adults with lipodystrophy.

Below is what the two current Egrifta labels say about dose, schedule, injection sites and treatment length, where they are silent, and how dosing works with Peppi's pre‑filled 30 mg pen.

The short answer

Both FDA labels call for one injection a day under the skin of the abdomen: 1.28 mg for Egrifta WR or 1.4 mg for Egrifta SV, in HIV-infected adults with lipodystrophy. Per the WR label, the two are not substitutable. Outside that use there is no standard dose, so a Peppi clinician sets yours from your intake.

  • Egrifta WR label: 1.28 mg once daily, for HIV lipodystrophy
  • Egrifta SV label: 1.4 mg once daily, not substitutable with WR
  • Your Peppi clinician sets your dose, dialed on a 30 mg pen
  • Peppi recommends 4 to 6 months for results to build

Chapter 01 of 08

How tesamorelin dosage is set

Two labels, two doses

Tesamorelin dosage depends on which product you mean. FDA‑approved tesamorelin is sold as Egrifta, and its two current labels, Egrifta WR and Egrifta SV, each set their own dose for one group: HIV‑infected adults with lipodystrophy.

According to the Egrifta WR prescribing information, the formulations differ in dosage, the number of vials needed to prepare a dose and reconstitution steps. It then says it plainly: "EGRIFTA WR and EGRIFTA SV are not substitutable." The Egrifta SV label gives its own dose for its own vial.

Peppi's Tesamorelin pen is not Egrifta, so neither label hands you a tesamorelin peptide dosage for it. It is a prescription filled by a licensed U.S. pharmacy, and a clinician licensed in your state personalizes the dose from your intake. Peppi's tesamorelin dosage per pen is 30 mg, a one‑month supply.

Where did the label dose come from? A 2011 tesamorelin lipodystrophy review in HIV/AIDS (Auckland) describes a 12‑week trial in 61 HIV patients that compared 1 mg and 2 mg daily. Visceral fat dropped more in the 2 mg group, and the two 26‑week trials that followed used 2 mg of the original formulation.

Every pen batch is tested before it ships. Match the lot number on your pen label against Peppi's batch test results.

DetailEgrifta WREgrifta SV
Vial strength11.6 mg per vial2 mg per vial
Labeled dose1.28 mg1.4 mg
How oftenOnce dailyOnce daily
WhereUnder the skin of the abdomenUnder the skin of the abdomen
Approved forHIV‑infected adults with lipodystrophyHIV‑infected adults with lipodystrophy

Current Tesamorelin batch results

LotTS91526
PublishedOct 12, 2026
Purity99.74%
Label claim30 mg
Measured31.481 mg
pH6.5 (range 4.5 to 7.0)
Endotoxins<3.75 EU/mL
SterilityRapid screen (qPCR)

Key takeawayLabel doses belong to Egrifta in HIV lipodystrophy. Your Peppi dose comes from your clinician.

Chapter 02 of 08

Tesamorelin dosage per day

Once a day, on the label

Both labels give the tesamorelin dosage per day as one injection: 1.28 mg once daily for Egrifta WR, 1.4 mg once daily for Egrifta SV.

That is where they stop. Neither label names a time of day or ties the dose to meals, sleep or training. Each patient leaflet simply says to use it "exactly as your healthcare provider tells you to use it."

With Peppi, your daily amount is the one your clinician prescribes, and you don't measure it. You dial each prescribed dose on the twist‑to‑dose selector, and refills come every 28 days.

Key takeawayThe labels say once daily. Your clinician sets the amount and the timing.

Chapter 03 of 08

Reading a tesamorelin dosage chart

Why charts exist at all

A tesamorelin dosage chart exists because of vials. Vial tesamorelin, Egrifta included, comes as a powder that must be mixed with liquid before injection, and after mixing, the drug in each syringe mark depends on how much liquid went in.

A tesamorelin dosage calculator does that conversion, turning a prescribed dose into a volume to draw up. Even the brand products carry this step. Egrifta WR's label has you mix one vial and draw daily doses from it for 7 days. Each Egrifta SV vial is mixed for a single dose, and the rest is thrown away.

A pre‑filled pen removes the math. Peppi's pen arrives filled with your prescription, so there is nothing to mix, reconstitute or measure from a vial. What your clinician works from instead is you: your intake, health history and goals, and how you respond as the plan goes on.

TipFound a chart online? Don't use it to change your dose. Ask your care team first.

Key takeawayCharts and calculators solve vial math. A pre‑filled pen has none to solve.

Chapter 04 of 08

Tesamorelin dosage for fat loss

What the label rules out

No label gives a tesamorelin dosage for fat loss in general. Egrifta WR's label says it "is not indicated for weight loss management as it has a weight neutral effect."

What the label covers is visceral fat, the deep fat around the organs, in one population. In its two trials, 412 and 404 HIV‑infected adults with lipodystrophy and excess abdominal fat took a daily injection or placebo for 26 weeks. Visceral fat fell 18% and 14% on tesamorelin, compared with a 2% rise and a 2% drop on placebo.

Outside HIV, a 2012 trial gave tesamorelin or placebo to 60 abdominally obese adults with reduced growth hormone secretion for 12 months. Visceral fat fell on tesamorelin, and the fat just under the skin of the abdomen did not change significantly. It was not a dosing study, and no label covers people without HIV.

Peppi lists visceral fat reduction among what Tesamorelin may support. Your clinician decides whether it fits your goals, then sets the dose.

Key takeawayNo label has a fat‑loss dose. The approved use is abdominal fat in HIV lipodystrophy.

Chapter 05 of 08

Tesamorelin dosage cycle

No off weeks on the label

Neither label describes a tesamorelin dosage cycle. There are no on and off weeks, no scheduled break and no maximum length of treatment.

Stopping was tested, though. People who finished 26 weeks were re‑randomized to stay on tesamorelin or switch to placebo for 26 more weeks. Visceral fat rose 22% and 16% in the two switch groups, while it held level in one stay‑on group and fell 5% in the other.

On continuing, the label says to "consider risk/benefit of continuation of treatment in patients who have not had a reduction in visceral adipose tissue," and notes that long‑term effects on the heart and blood vessels are not established. It also lists reasons to reconsider treatment:

  • IGF‑1 that stays high, for example above 3 SDS
  • New glucose intolerance or diabetes without a clear response
  • A suspected allergic reaction, which means stopping and getting medical help
  • Pregnancy, critical illness or a cancer that comes back

TipWith Peppi, plan length is your clinician's decision. Peppi recommends committing 4 to 6 months for results to build, and your plan can change as your progress does.

Key takeawayThe label sets no cycle. In the trials, visceral fat came back after a switch to placebo.

Chapter 06 of 08

Tesamorelin dosage for bodybuilding

No dose, and banned in sport

There is no tesamorelin dosage for bodybuilding. Labeled doses exist only for HIV‑infected adults with lipodystrophy, and the trials measured visceral fat as their main result. Lean body mass rose 1.3 kg and 1.2 kg over 26 weeks in those patients, but the studies were not built to test muscle size or strength.

Tested athletes face a second issue. The 2026 WADA Prohibited List bans growth hormone releasing factors at all times, in and out of competition, and names tesamorelin, CJC‑1295 and ipamorelin among them. That covers Peppi's CJC + Ipamorelin pen too.

If lean body composition is your goal, say so in your intake. Your clinician decides which pen, if any, fits.

Good to knowCompeting athletes: tesamorelin, CJC-1295 and ipamorelin are all on the 2026 WADA Prohibited List, banned at all times.

Key takeawayNo labeled bodybuilding dose exists, and tesamorelin is prohibited in tested sport.

Chapter 07 of 08

How to take tesamorelin

Under the skin, by pen

Both labels give the same answer on how to take tesamorelin: inject it under the skin of the abdomen, change the spot with each dose, and stay away from scar tissue, bruises and the navel.

Rotation matters because site reactions are common. Over the first 26 weeks of the trials, 25% of tesamorelin patients had one, compared with 14% on placebo, including redness, itching, pain, irritation or bruising.

How to inject tesamorelin with Peppi is simpler than with a vial. Your pen arrives pre‑filled, the twist‑to‑dose selector sets the dose your clinician prescribed, and your care team answers questions by message or video call. Pens, dosing and refills are covered on the Peppi FAQs page.

The WR label adds one more rule: never share a syringe with another person, even if the needle is changed.

$224first month$44950% offthen $359 a month

Not sure Tesamorelin fits your goals?

Take the Quiz

Key takeawayInject under the skin of the abdomen and rotate sites. Your pen comes ready to use.

Chapter 08 of 08

When tesamorelin starts working

Six months, in stages

How long does tesamorelin take to work? In the label trials, the main result was measured at 26 weeks, in HIV‑infected adults with lipodystrophy.

Other timepoints come from smaller studies. In a 12‑week dose‑ranging trial of 61 HIV patients, trunk fat fell 9.2% in the 2 mg group, against a 0.8% rise on placebo. Outside HIV, the 2012 obesity trial ran 12 months.

Peppi describes the first six months in stages, and recommends committing 4 to 6 months because peptide therapy is cumulative.

  1. Week 1

    Build the routine

    Set a baseline for sleep, recovery, training, energy, and body composition. Commit to following the plan consistently.

  2. Weeks 2 to 4

    Feel early signals

    Pay attention to changes in sleep, recovery, energy, and how you feel going into your workouts.

  3. Months 2 to 3

    See measurable progress

    Changes in recovery, training consistency, waist measurement, or body composition may become easier to measure.

  4. Months 4 to 6

    Sustain the benefit

    The goal is lasting results that show up in how you look, feel, and perform.

Stages as Peppi describes them on its Tesamorelin page. Applies only if a practitioner prescribes treatment. Onset and response vary by individual, and the stages are not a guarantee of outcomes.

Key takeawayTrials read results at 26 weeks. Peppi recommends 4 to 6 months.

Questions about tesamorelin dosage

Frequently asked questions

What Is the Standard Tesamorelin Dose?

The standard doses are on the FDA labels, and they apply to HIV-infected adults with lipodystrophy. Egrifta WR is 1.28 mg once daily and Egrifta SV is 1.4 mg once daily, and the WR label says the two are not substitutable. For anyone else there is no standard dose, so a Peppi clinician sets yours from your intake.

Should You Take Tesamorelin at Night?

The Egrifta labels do not specify a time of day. They say once daily, under the skin of the abdomen with rotating sites, and each patient leaflet says to use it exactly as your healthcare provider tells you. With Peppi, your clinician decides your timing as part of your plan, and your care team can answer questions anytime.

Do You Cycle Off Tesamorelin?

The labels set no cycle or off weeks. In the trials, people switched to placebo after 26 weeks saw visceral fat climb back, and the label asks prescribers to weigh continuing in patients whose visceral fat has not dropped. Whether and when to stop is your clinician's decision. Peppi recommends committing 4 to 6 months for results to build.

*These statements have not been evaluated by the Food and Drug Administration. Peppi peptides are dispensed only with a prescription.

Peptide guides from Peppi

Keep reading